title: Illicit drugs in Central Asia: what we know, what we don’t know, and what we need to know.
authors.forename: Alisher
authors.initials: A
authors.lastname: Latypov
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Grund
authors.forename: Nabila
authors.initials: N
authors.lastname: El-Bassel
authors.forename: Lucy
authors.initials: L
authors.lastname: Platt
authors.forename: Heino
authors.initials: H
authors.lastname: Stöver
authors.forename: Steffanie
authors.initials: S
authors.lastname: Strathdee
mesh_terms: D001209:Asia, Central / Q000453:epidemiology; D003415:Crime; D062787:Drug Overdose / Q000401:mortality; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology*; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects* / Q000191:economics; D035846:Law Enforcement; D011330:Prisons; D012747:Sexual Partners; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000453:epidemiology*; D014376:Tuberculosis / Q000150:complications* / Q000453:epidemiology
chemical_list: D013287:Illicit Drugs